Teens vaccinated with Pfizer jab are well protected against Delta variant, study finds

accreditation
Share your Subscriber Article
You have 5 articles to share every month. Send this story to a friend!
0:00
play article
Subscribers can listen to this article
Covid 19 vaccination
Covid 19 vaccination
Capuski

The two-dose Pfizer-BioNTech Covid-19 vaccine provides adolescents with effective protection, a large Israeli study has found.

The analysis was based on data from nearly 200 000 adolescents (94 354 vaccinated and 94 354 unvaccinated) aged 12 to 18.

It showed that fully vaccinated participants were 93% less likely than their unvaccinated peers to contract symptomatic (displaying symptoms) infection with the Delta variant in the first few weeks after receiving their second dose.

Support independent journalism
Subscribe to News24 for just R75 per month to read all our investigative and in-depth journalism. You can cancel any time.
Subscribe
Already a subscriber? Sign in
Voting Booth
Have you entered our Health of the Nation survey?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes
29% - 9758 votes
No
71% - 24094 votes
Vote